Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy
8940 N. Wood Sage Rd | Peoria, IL 61615-7822
